Sabtu, 02 Januari 2021

US Senator Cruz leads long-shot Republican bid to overturn Biden's victory - CNA

WASHINGTON: US Senator Ted Cruz on Saturday (Jan 2) said he will spearhead a drive by nearly a dozen Republican senators to challenge President-elect Joe Biden’s victory when Electoral College results are tallied in Congress on Jan 6 – a largely symbolic move that has virtually no chance of preventing Biden from taking office.

Cruz's effort is in defiance of Senate Republican leaders, who have argued that the Senate's role in certifying the election is largely ceremonial and had been looking to avoid an extended debate on the floor about the outcome.

In a statement, Cruz, the US senator from Texas, and the other 10 senators said they intend to vote to reject electors from states that have been at the centre of President Donald Trump’s unproven assertions of election fraud. They said Congress should immediately appoint a commission to conduct an emergency 10-day audit of election results in those states.

Candidates campaign before runoff races in Georgia for control of U.S. Senate
U.S. Senator Ted Cruz (R-TX) attends a campaign event ahead of runoff races in Georgia for control of U.S. Senate, in Cumming, Georgia, U.S., January 2, 2021. REUTERS/Elijah Nouvelage

"Once completed, individual states would evaluate the commission's findings and could convene a special legislative session to certify a change in their vote, if needed," they said.

It was not immediately clear which states would be subject to the proposed audit, Cruz's office said.

READ: US Electoral College formally confirms Joe Biden's victory over Trump

Commentary: How Joe Biden won the 2020 US presidential election

Michael Gwin, a spokesman for the Biden campaign, dismissed the move as theatre that is not supported by any evidence.

"This stunt won’t change the fact that President-elect Biden will be sworn in on Jan 20, and these baseless claims have already been examined and dismissed by Trump’s own attorney general, dozens of courts, and election officials from both parties," he said.

The push for an audit is a political stunt that will not affect the outcome of the election, said Derek Muller, a law professor at the University of Iowa.

Muller said that, while the 1887 law governing how lawmakers validate the election is murky, most scholars believe that Congress lacks the legal authority to require the audit. Even if lawmakers had that power, a majority of both chambers would need to support the audit, and there is virtually no chance of the proposal having that level of support, he said.

Biden beat Trump by a 306-232 margin in the Electoral College.

Under the Electoral College system, "electoral votes" are allotted to states and the District of Columbia based on their congressional representation.

Trump has been encouraging Republicans to prevent Biden from taking office, although there is no viable mechanism for them to do so.

Legal challenges by Trump and his allies in the courts to overturn the election results have met with resounding failure. On Friday, a federal judge threw out a lawsuit brought by Representative Louie Gohmert that sought to allow Vice President Mike Pence, who presides over the Congressional tally, to declare Trump the victor on Jan 6.

READ: Trump campaign will again ask US high court to upend election results

READ: Biden says Trump 'refused to respect the will of the people'

The effort by Cruz and other Republicans comes days after US Senator Josh Hawley of Missouri became the first sitting member of the Senate to announce he would challenge the election result. A number of Republicans in the US House of Representatives also plan on contesting the vote tally.

Cruz was joined in the statement by Senators Ron Johnson, James Lankford, Steve Daines, John Kennedy, Marsha Blackburn, Mike Braun, along with Senators-elect Cynthia Lummis, Tommy Tuberville, Bill Hagerty, and Roger Marshall, all of whom will be sworn in as senators on Sunday in the new Congress.

Several Republicans senators have said they do not support any effort to derail the certification of the Electoral College vote.

Majority Leader Mitch McConnell, the Senate’s top Republican, acknowledged Biden’s victory on Dec 15 and has urged other Republicans to refrain from objecting on Jan 6.

Republican Senator Pat Toomey of swing state Pennsylvania criticised Cruz and others for undermining the will of voters to choose their leaders and said Trump's loss in his state is due to the decline in suburban support for the president and loss of support in most rural counties, not fraud.

"I intend to vigorously defend our form of government by opposing this effort to disenfranchise millions of voters in my state and others," he said.

In Cruz's statement, the senators said they did not necessarily expect their gambit to succeed.

"We are not naive. We fully expect most if not all Democrats, and perhaps more than a few Republicans, to vote otherwise," they said.

Pence's chief of staff, Marc Short, said in a statement on Saturday that lawmakers have the right to raise their objections.

"The Vice President welcomes the efforts of members of the House and Senate to use the authority they have under the law to raise objections and bring forward evidence before the Congress and the American people on Jan 6," Short said. 

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMidGh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy93b3JsZC91cy1zZW5hdG9yLWNydXotbGVhZHMtbG9uZy1zaG90LXJlcHVibGljYW4tYmlkLXRvLW92ZXJ0dXJuLWJpZGVuLTEzODgyMzk00gEA?oc=5

2021-01-02 23:26:15Z
52781281845106

'Hire Me': Thai project gives homeless people a better chance at life - CNA

BANGKOK: A group of people were hard at work on the dusty roadside by a railway. 

Wearing yellow aprons and black gloves, they swept dry leaves into piles and scooped up garbage with their hands. Their faces are wrinkled and beaded with sweat while their skin burned in the scorching sun. But they are happy to do it every week.

“The job is easy but you have to be clean and focused. You can’t just do it for fun,” said one of the cleaners, Chalee Maneeterm.

Like his colleagues, Chalee is a participant of the Hire Me project or "Jangwan Ka" in Thai, which seeks to provide jobs for people with no home or on the brink of becoming homeless.

The initiative was launched in July by the Mirror Foundation, a non-governmental organisation that has advocated social development in Thailand since 1991. So far, the project has attracted about 100 participants. Most of them are aged between 55 and 70 and do not have enough funds to start a new life on their own.

“I stay at a market. There’s a place for me to sleep there but it’s not really meant for that. I can use it, though, without causing trouble to anyone. Sometimes, people give me things,” Chalee said when interviewed by CNA.

An elderly woman picks up a piece of rubbish on the roadside in Bangkok
An elderly woman picks up a piece of rubbish on the roadside in Bangkok. (Photo: Pichayada Promchertchoo)

Three years ago, an accident cost him the sight of his left eye and forced him to spend his savings on medical bills. Life has since become a struggle with jobs proving hard to find. 

People think he is “incomplete”, he said, but things got even worse with the COVID-19 pandemic.

Chalee has no permanent job and relies on charity to get buy. Each time he wants to have a shower, he has to find 10 baht (US$0.34) to use bathrooms or go to a temple that would allow him to use the facility for free.

“If I have a chance, I’d like to do something else to make myself better and not have to depend on others all the time,” he said.

Chalee is one of more than 2,700 people with no home in Thailand, according to a survey in January by the Ministry of Social Development and Human Security and related organisations. 

Data showed 86 per cent of this vulnerable group were male and more than half lived alone. They are scattered across the country but concentrated in big cities such as Bangkok, Nakhon Ratchasima, Chiang Mai and Songkhla.

A group of cleaners fill a plastic bag with rubbish and dry leaves
A group of cleaners fill a plastic bag with rubbish and dry leaves as part of the Hire Me project. (Photo: Pichayada Promchertchoo)

“The root cause of the problem is that these people have a home but they can’t live there for various reasons, for example, a financial problem with people in their house. They feel they can no longer stay there and choose to leave. But they don’t have any capital that’d allow them to, let’s say, rent a room or stay with friends for two months while looking for a job,” said Hire Me project manager Sittiphol Chuprajong.

“In most cases, homeless people have very little capital – limited education, hardly any savings and even their age; most of them are elderly,” he added. “It makes them unable to find jobs.”

As a result, thousands of people have ended up on the streets and public areas such as train stations, bus stops and parks.

“DON’T HAVE TO RUN TO BEG FOR FOOD ANYMORE”

Since July, the Hire Me project has provided a number of homeless people with cleaning jobs. Sittiphol and his team coordinate with the Bangkok Metropolitan Administration in sourcing public areas for them to clean at least once a week. 

The venues range from pedestrian bridges to parks and pavements. Each session lasts three to four hours and the cleaners get paid 400 baht (US$13).

“Almost every single one of them are enthusiastic to work because they feel they get to do something with their life instead of having to beg all the time,” Sittiphol said.

A male cleaner sweeps dry leaves on the roadside in Bangkok
A male cleaner sweeps dry leaves on the roadside in Bangkok. (Photo: Pichayada Promchertchoo)

For those who are serious about saving up, they can opt for working four times a week to earn more. One of them is Natcha Sangyot, who became homeless at the age of 54.

Like Chalee, the COVID-19 pandemic made it hard for her and her sister to find a job. With no money to rent a room, the pair had to stay around a bus stop in Bangkok and live on charity. They had to queue for hours in the sun every day to receive food donations. At night, they had to be careful about lurking dangers.

“We would sit at the bus stop the whole night and take turns sleeping,” Natcha said.

There were other homeless people there and they’d grope us. Some taxi drivers came to grab our hands. Sometimes when we were asleep, people would steal our belongings – shoes and bags. That’s how it was. So, we had to be careful.

A participant of the Hire Me project
The Hire Me project helps homeless and vulnerable people in Bangkok improve their life by providing them with jobs. (Photo: Pichayada Promchertchoo)

Natcha and her sister lived on the streets for weeks before someone introduced them to the Hire Me project. Then life began to change. With regular income, they have been able to save money, rent a room and stop taking turns to sleep at night.

“Life is much better now as we don’t have to stand in the sun or sit in the square all day,” Natcha said.

“I don’t have to run to beg for food anymore. We have some savings to pay for showers and to buy food without having to queue for hours with other people,” she added. “I’m proud.”

“THESE LITTLE THINGS WE TAKE FOR GRANTED”

Natcha has been paying rent herself for three months now. The joy of having financial independence makes her continue to work hard. But not everyone on the streets can achieve what she has done.

Through years of working with homeless people in Thailand, Sittiphol has discovered that a key challenge faced by this vulnerable group is a lack of stable jobs and access to basic facilities such as bathrooms, toilets and laundry areas, which affects their quality of life.

While the government provides shelters for homeless people, he said very few of them want that kind of support because it is not compatible with their lifestyle.

“Most residents of state shelters have mental health problems – about 80 per cent of them. This makes ordinary people like those with no home feel suffocated if they have to stay there, where they’ll be put together, sleep together and share the same space. They can’t handle it,” Sittiphol told CNA.

“Also, there is no freedom. They can’t really go anywhere and that doesn’t suit their lifestyle, which involves finding income,” he added.

According to Sittiphol, homeless people in Thailand have different needs and not all of them want to have a home. To help improve their life, social workers who run the Hire Me project chose to target unemployment among the homeless population. They believe a key factor that could help them transform and improve their quality of life is a job.

“They can buy new clothes and products to look after themselves such as soap and toothpaste. They can take care of themselves more often. Those who pay to use bathrooms can shower more,” Sittiphol said.

These little things we take for granted mean a lot to them. They want to be clean. They want to shower. And to be able to spend money without having to beg means much to them. It brings back their pride, as these people normally have to wait for charity.

“When they have income, they’ll also think ‘What should I do with the money?’. So this will lead to a certain decision that’s important to their life, for example, find a place to live that’s not on the streets or public places,” he added.

Chalee Maneeterm
Chalee Maneeterm. (Photo: Pichayada Promchertchoo)

On the roadside, black garbage bags are filled with dry leaves and rubbish. Work has been finished and the cleaners were preparing to go home. Chalee may not have one to go back to just yet but he is working on it.

“I would like to have a gas stove and sell fried chicken with sticky rice in the morning,” he said.

“I may be disabled but I’m 100 per cent ready,” he added. “I can see the whole world, not just half of it.”

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMiVGh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL3RoYWlsYW5kLWhvbWVsZXNzLWhpcmUtbWUtcHJvamVjdC0xMzgxMjA5NtIBAA?oc=5

2021-01-02 22:05:44Z
CBMiVGh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL3RoYWlsYW5kLWhvbWVsZXNzLWhpcmUtbWUtcHJvamVjdC0xMzgxMjA5NtIBAA

India holds COVID-19 vaccine drills ahead of mass inoculation drive - CNA

NEW DELHI: India on Saturday (Jan 2) staged nationwide drills to start one of the world's biggest coronavirus vaccination programmes as the drug regulator prepared to approve the first vaccine.

A government panel on Friday recommended emergency use of the AstraZeneca-Oxford University shot and the first injections could be given in the coming week after the Drugs Control Authority of India gives final approval. 

India, which has the world's second-highest number of pandemic cases - more than 10.2 million - has set an ambitious target of inoculating 300 million of its 1.3 billion people by mid-2021.

Serum Institute of India, the world's biggest vaccine producer, has already stockpiled tens of millions of doses of AstraZeneca's Covishield ready for the campaign and 96,000 health workers have been trained for the inoculation drive.

READ: Britain approves AstraZeneca-Oxford COVID-19 vaccine

The drills saw 25 health workers receive dummy vaccines at each of the centres to be used across the country in a test run ahead of the launch.

Health minister Harsh Vardhan said the exercise would help build expertise "so that the upcoming vaccination drive may proceed without any glitch". He has also called for a campaign to counter "misleading rumours" that may scare people off getting the vaccine.

While India is only second to the United States for the number of cases, its rate of infection has come down significantly from a mid-September peak of 90,000 plus cases daily and its fatality rate is lower than other badly affected countries.

Britain and Argentina this week authorised the AstraZeneca vaccine while the World Health Organization on Thursday granted emergency validation to the rival Pfizer-BioNTech vaccine.

Covishield is expected to get more use in India as it can be stored and transported under normal refrigeration while the Pfizer shot needs ultra-low temperatures for storage.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMicWh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL2luZGlhLWNvdmlkLTE5LXZhY2NpbmUtYXN0cmF6ZW5lY2EtZHJpbGxzLWZvci1tYXNzLWlub2N1bGF0aW9uLTEzODgwODA40gEA?oc=5

2021-01-02 07:57:54Z
52781280914969

Japan to consider new COVID-19 emergency declaration - CNA

[unable to retrieve full-text content]

  1. Japan to consider new COVID-19 emergency declaration  CNA
  2. Tokyo calls for state of emergency over virus third wave  Yahoo Singapore News
  3. Tokyo to request new emergency declaration as Covid-19 cases climb, say local reports  AsiaOne
  4. Japan's stance against emergency appears to shift as cases soar  The Straits Times
  5. Tokyo governor, others urge Japan's government to declare coronavirus emergency  Yahoo Singapore News
  6. View Full coverage on Google News

https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL3Rva3lvLW5ldy1lbWVyZ2VuY3ktZGVjbGFyYXRpb24tYXMtY292aWQtMTktY2FzZXMtcmlzZS0xMzg4MDM0NtIBAA?oc=5

2021-01-02 07:55:26Z
52781280400876

Jumat, 01 Januari 2021

Different efficacy data for Sinopharm COVID-19 vaccine 'real and valid': Media - CNA

BEIJING: Different efficacy results for a Chinese COVID-19 vaccine released separately in China and in United Arab Emirates are both real and valid, an executive at China National Biotec Group (CNBG) told state media.

China approved its first COVID-19 vaccine for general public use on Thursday (Dec 31), a shot developed by an affiliate to state-backed Sinopharm, after the developer said the vaccine showed 79.34 per cent efficacy based on an interim analysis of late-stage clinical trials.

That rate is lower than the 86 per cent rate for the same vaccine reported by the United Arab Emirates on Dec 9.

Countries have certain differences in their standards and procedures in diagnosing patients, and the final results of COVID-19 case identification were different, Yang Xiaoming, chairman at Sinopharm unit's CNBG, told Global Times, a tabloid published by the People's Daily, the official newspaper of China's ruling Communist Party.

READ: China gives its first COVID-19 vaccine approval to Sinopharm

"Therefore, there were differences between the comprehensive multi-country data we reviewed and the protection rate data previously evaluated by the UAE and Bahrain," Global Times quoted Yang as saying in a report published on Thursday.

"But these two results are both real and valid," Yang said, without offering further details for the data.

READ: Chinese COVID-19 vaccines are poised to fill gap, but will they work?

CNBG did not participate in the analysis or review of clinical trial data released by regulators in countries where its vaccine was being trialled, Yang said.

The vaccine, developed by CNBG's unit Beijing Biological Products Institute, along with another candidate from a Wuhan-based unit of CNBG, are being tested in Phase III clinical trials outside China.

Trials for CNBG's candidates have recruited over 60,000 participants aged between 18 and 60, Yang said.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMiXGh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL2NoaW5hLWNvdmlkLTE5LXNpbm9waGFybS12YWNjaW5lLWVmZmljYWN5LTEzODgwNTQ40gEA?oc=5

2021-01-02 04:51:09Z
52781280537462

Defying Trump, Republican-led US Senate overrides defense Bill veto - CNA

WASHINGTON: President Donald Trump's fellow Republicans in the US Senate on Friday (Jan 1) overrode his veto for the first time in his nearly four years in office, pushing through a Bill on defense spending against his strong objections 20 days before he leaves office.

Meeting in a rare New Year's Day session, the Senate voted 81-13 to achieve the two-thirds majority needed to override the veto with bipartisan support two days before a new Congress will be sworn in on Sunday. Eight previous vetoes have been upheld.

Republican lawmakers have largely stood by the president during his turbulent four years in the White House. Since losing his re-election bid in November, Trump has lashed out at them for not fully backing his unsupported claims of voting fraud, rejecting his demand for bigger COVID-19 relief checks and for moving toward the veto override.

The Republican-led Senate reconvened midday to take up the US$740 billion National Defense Authorization Act (NDAA), which Trump refused to sign into law because it does not repeal certain legal protections for tech companies. He also objects to a provision stripping the names of Confederate generals from military bases.

Senators are expected to cast the first of two procedural votes aimed at overriding Trump's veto, after the House of Representatives successfully voted to overturn it on Monday. If that succeeds, the Senate would then hold a second procedural vote followed by a final vote on passage on its last day in session on Saturday.

READ: Trump back in Washington early amid showdown with Congress

READ: McConnell thwarts Trump bid for US$2,000 coronavirus economic relief checks

Democrats, who in an unusual alignment with Trump welcomed his call for US$2,000 direct relief payments, had hoped to use the NDAA to force a swift vote on a Bill authorising the checks, which would give Americans more than the US$600 coming now. Some Republicans also back larger payouts.

But Senate Republican Leader Mitch McConnell quashed the effort, tying larger checks to a competing Bill with social media and election provisions that Democrats are sure to reject with little time left for maneuvering before the next Congress is sworn in on Sunday.

Trump, who returned to Washington on Thursday from his private club in Florida, has ramped up pressure on fellow Republicans and slammed party leadership for failing to do his bidding on the two measures.

"Weak and tired Republican 'leadership' will allow the bad Defense Bill to pass," he said in a string of tweets this week, adding: "Unless Republicans have a death wish ... they must approve the US$2000 payments ASAP!"

Republican tensions are also rising over some conservatives' plan to object next Wednesday when the new Congress officially tallies the Electoral College votes certifying Democrat Joe Biden's presidential victory before he is sworn in on Jan 20.

McConnell, who publicly acknowledged Biden's win, on Thursday raised questions in a call with his caucus over fellow Republican Senator Josh Hawley's plan to object, according to media reports. At least 140 Republicans in the House are expected to launch similar objections despite Congress' largely ceremonial role, CNN reported.

Representatives for McConnell did not respond to a Reuters query seeking comment on the planned maneuvers, which could trigger a lengthy Senate debate but have no chance of overturning the results.

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMiX2h0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy93b3JsZC91cy1zZW5hdGUtb3ZlcnJpZGVzLXRydW1wLWRlZmVuc2UtYmlsbC12ZXRvLTEzODc4NTE20gEA?oc=5

2021-01-01 19:52:30Z
52781274841635

India's drug regulator approves AstraZeneca/Oxford vaccine, country's first: Sources - CNA

NEW DELHI: India's drug regulator on Friday (Jan 1) approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters. 

The decision clears the vaccine's rollout in the world's second-most populous country which, after the United States, has the highest number of COVID-19 infections.

India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.

A representative of India's Central Drugs Standard Control Organization (CDSCO), whose experts were meeting for the second time this week, declined to comment.

READ: How does AstraZeneca's COVID-19 vaccine compare with Pfizer-BioNTech?

READ: India tests COVID-19 vaccine delivery systems ahead of emergency approval

Britain and Argentina have already authorised the vaccine for urgent public use.

The CDSCO is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech.

Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.

Countries with relatively basic health infrastructure have high hopes for a shot that, unlike Pfizer's, can be stored and transported under normal refrigeration, rather than supercooled to -70 degrees Celsius.

India has reported more than 10 million COVID-19 cases, though its rate of infection has come down significantly from a mid-September peak. The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of 2021.

DOSING REGIMEN

Britain became the first country this week to authorise the AstraZeneca vaccine, moving ahead of other western countries as it seeks to stem a record surge of infections driven by a highly contagious form of the virus that has also surfaced in India.

The AstraZeneca shot is being manufactured in India by Serum Institute of India (SII), the world's biggest producer of vaccines, which has already stockpiled about 50 million doses.

Though the Indian government has not yet signed a purchase agreement with SII, the company says it will focus on the home market first, and then exports - mainly to South Asian countries and Africa.

READ: India extends UK flight ban over new coronavirus variant as it races to locate previous arrivals

SII did not immediately respond to an email request seeking comment.

Questions about the degree of effectiveness of the AstraZeneca shot have surrounded it since data published in November showed a divergence in success rates, which the developers said reflected different dosing regimens.

Britain's medicines regulator further clouded the picture this week when it said that it had found an 80 per cent success rate when two full doses were administered, three months apart, higher than the average that the developers themselves had found. 

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMicmh0dHBzOi8vd3d3LmNoYW5uZWxuZXdzYXNpYS5jb20vbmV3cy9hc2lhL2FzdHJhemVuZWNhLWNvdmlkLTE5LXZhY2NpbmUtaW5kaWEtZmlyc3QtYXBwcm92YWwtZW1lcmdlbmN5LXVzZS0xMzg3NzUyMNIBAA?oc=5

2021-01-01 13:07:30Z
52781279475239